Promising Outlook for MoonLake’s Sonelokimab in Psoriatic Arthritis Treatment
MoonLake Immunotherapeutics (MLTX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday.
Enlivex Announces the Dosing of the First Patient in a Phase I Clinical Trial Evaluating Allocetra in Patients with Psoriatic Arthritis
Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced the completion of the dosing and initial follow-up period for ...
Healthline5d
What Biologics Are Out on the Market?
For example, one person with psoriatic arthritis may respond well to a TNF ... Biologics can be used as first-line treatment for some conditions. However, your doctor may recommend starting ...
rheumatologyadvisor4d
Secukinumab vs Adalimumab More Effective for Skin Symptoms in PsA
Similar percentages of patients with PsA receiving secukinumab vs adalimumab achieved an ACR20 response at 12 weeks.
Too Old to Operate1d
Impact of Depression and Anxiety on Remission in Arthritis
The following is a summary of “Association between depression and anxiety and inability to achieve remission in rheumatoid ...
Business Wire2d
Global Healthy Living Foundation Brings Innovative and Patient-Centered Polymyalgia Rheumatica, Psoriatic, and Rheumatoid Arthritis Research to ACR Conv…
Global Healthy Living Foundation has 12 posters and Polymyalygia Rheumataca, Psoriasis and RA Research at American College of ...
Clinical autoimmune study: RA and PsO treatment through Project IMPACT
Discovering the best way to manage autoimmune conditions Project IMPACT invites individuals undergoing treatment with ...
emjreviews.com9d
Mechanistic Understanding of Clinical Response to Bimekizumab in Psoriatic Disease
Exacerbations of the chronic and progressive inflammatory disease bronchiectasis can impact quality of life. Treatment, based ...
Johnson & Johnson advances leadership in rheumatic disease innovation with 43 abstracts at ACR 2024
Johnson & Johnson (NYSE: JNJ) announced today that 43 presentations showcasing the Company's rheumatology pipeline and portfolio will be featured at the American College of Rheumatology (ACR) 2024 ...
Common Causes of Arthritis for Women (& How to Treat It)
Arthritis is a common acute or chronic condition affecting the joints and surrounding tissues. It’s estimated that roughly 18 ...